Email Us Here

Ryszard Kole Honored by Marquis Who's Who for Excellence in Biotechnology and Pharmaceuticals

Dr. Kole is credited with discovery of exon-skipping technology, building Ercole Biotech, a research stage biopharmaceutical company, and contributions to development of Eteplirsen (Exondys 51), a drug for treatment of Duchenne muscular dystrophy